These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monoamine metabolites in CSF and suicidal behavior. Träskman L; Asberg M; Bertilsson L; Sjöstrand L Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274 [TBL] [Abstract][Full Text] [Related]
3. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Engström G; Alling C; Blennow K; Regnéll G; Träskman-Bendz L Eur Neuropsychopharmacol; 1999 Sep; 9(5):399-405. PubMed ID: 10523046 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid monoamine metabolites and suicide. Jokinen J; Nordström AL; Nordström P Nord J Psychiatry; 2009; 63(4):276-9. PubMed ID: 19034712 [TBL] [Abstract][Full Text] [Related]
5. Amine metabolites, neuroendocrine findings, and personality dimensions as correlates of suicidal behavior. Banki CM; Arató M Psychiatry Res; 1983 Dec; 10(4):253-61. PubMed ID: 6199807 [TBL] [Abstract][Full Text] [Related]
6. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide. Roy A; Ninan P; Mazonson A; Pickar D; Van Kammen D; Linnoila M; Paul SM Psychol Med; 1985 May; 15(2):335-40. PubMed ID: 2410941 [TBL] [Abstract][Full Text] [Related]
7. A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Mann JJ; Currier D Arch Suicide Res; 2007; 11(1):3-16. PubMed ID: 17178639 [TBL] [Abstract][Full Text] [Related]
8. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071 [TBL] [Abstract][Full Text] [Related]
9. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls. Bertilsson L; Asberg M; Lantto O; Scalia-Tomba GP; Träskman-Bendz L; Tybring G Psychiatry Res; 1982 Feb; 6(1):77-83. PubMed ID: 6173891 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Lindqvist D; Janelidze S; Hagell P; Erhardt S; Samuelsson M; Minthon L; Hansson O; Björkqvist M; Träskman-Bendz L; Brundin L Biol Psychiatry; 2009 Aug; 66(3):287-92. PubMed ID: 19268915 [TBL] [Abstract][Full Text] [Related]
11. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Lester D Pharmacopsychiatry; 1995 Mar; 28(2):45-50. PubMed ID: 7542785 [TBL] [Abstract][Full Text] [Related]
12. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628 [TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid studies in suicide. An overview. Asberg M; Nordström P; Träskman-Bendz L Ann N Y Acad Sci; 1986; 487():243-55. PubMed ID: 2436537 [No Abstract] [Full Text] [Related]
14. Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide. Roy A; Lamparski D; De Jong J; Adinoff B; Ravitz B; George DT; Nutt D; Linnoila M Acta Psychiatr Scand; 1990 Jan; 81(1):58-61. PubMed ID: 1691893 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Mann JJ; Malone KM Biol Psychiatry; 1997 Jan; 41(2):162-71. PubMed ID: 9018386 [TBL] [Abstract][Full Text] [Related]
17. Life at risk: markers of suicidality in depression. Agren H Psychiatr Dev; 1983; 1(1):87-103. PubMed ID: 6201842 [TBL] [Abstract][Full Text] [Related]
18. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Mann JJ; Malone KM; Sweeney JA; Brown RP; Linnoila M; Stanley B; Stanley M Neuropsychopharmacology; 1996 Dec; 15(6):576-86. PubMed ID: 8946432 [TBL] [Abstract][Full Text] [Related]
19. CSF metabolites in borderline personality disorder compared with normal controls. Gardner DL; Lucas PB; Cowdry RW Biol Psychiatry; 1990 Aug; 28(3):247-54. PubMed ID: 1696137 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid monoamine metabolite concentrations in suicide attempt: A meta-analysis. Sharma R; Tikka SK; Yadav AK; Bhute AR; Dhamija P; Bastia BK Asian J Psychiatr; 2021 Aug; 62():102711. PubMed ID: 34090249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]